WASHINGTON — As they jostle to position themselves for 2020, many Democratic presidential hopefuls have suddenly zeroed in on a narrow policy target: prescription drug prices.
Sen. Bernie Sanders called his first press conference since the midterms not to discuss President Trump’s quest for a wall or tout universalized health coverage, but to unveil a proposal to lower drug prices that mirrors one of Trump’s own. Sen. Cory Booker dialed up his own rhetoric to campaign-trail levels, decrying high drug prices as “a stain on the very idea of America.” The House Oversight Committee, too, set drug prices atop its own agenda, scheduling a hearing on that issue that will occur more than a week before it calls former Trump lawyer Michael Cohen to testify.
Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author
Well I hope Bernie Sanders realizes that one item in his proposal won’t fly with the PBM’s . He wants pharmacies to be able to buy drugs from Canada. That’s a no no ! The PBM’s need to get their VIG from the manufacturer’s ! If the NDC isn’t on their collection list then the pharmacy sleeps with the fish !!
I just hope these Senators realize that the problem is with the PBM’s ! Just ask
the people of Ohio or Kentucky or a dozen other states the PBM’s stole BILLIONS
of dollars from !! And no one gets indited ? I just don’t get it !!!!!